Research Output 1989 2019

Filter
Letter
2018

The DaXa-inhibition assay: A concept for a readily available, universal aXa assay that measures the direct inhibitory effect of all anti-Xa drugs

van Pelt, L. J., Lukens, M. V., Testa, S., Chatelain, B., Douxfils, J. & Mullier, F., 1 Aug 2018, In : Thrombosis Research. 168, p. 63-66 4 p.

Research output: Contribution to journalLetter

2016

Multiple causes of cardiotoxic effects in patients with chronic myeloid leukemia - Reply

Douxfils, J., Haguet, H. & Dogné, J. M., 1 Jun 2016, In : JAMA oncology. 2, 6, p. 829 1 p.

Research output: Contribution to journalLetter

2015
71 Downloads (Pure)

Criteria for prescribing dabigatrin extexilate and rivaroxaban really appropriate? Authors' reply

Larock, A. S., Mullier, F., Douxfils, J., Dogné, J. M. & Spinewine, A., 2015, In : The Annals of pharmacotherapy. 49, 1, p. 155

Research output: Contribution to journalLetter

Open Access
File
43 Downloads (Pure)
Open Access
File
Atrial Fibrillation
Thrombin
Observational Studies
Dabigatran
Prospective Studies
2014

Proactively managing the risk of marketed drugs: Experience with the EMA Pharmacovigilance Risk Assessment Committee

Arlett, P., Portier, G., De Lisa, R., Blake, K., Wathion, N., Dogne, J. M., Spooner, A., Raine, J. & Rasi, G., 1 Jan 2014, In : Nature Reviews Drug Discovery. 13, 5, p. 395-397 3 p.

Research output: Contribution to journalLetter